PerpEquities

Equity

BSX perpetual futures

Boston Scientific Corporation tracked across crypto venues with normalized contract specs.

Compare venues

Price chart

44.96 0.08%
44.0044.2044.4044.6044.80
01:39 PM02:34 PM03:30 PM04:25 PM05:20 PM
24/7 perp mark · BingX (BSX-USDT)
Auto: market closed → highest-volume perp venue

Trading data

Perpetual market activity

2/2 live markets
Venues
2
Live markets
2/2
24h volume
$236k
Open interest
$1k
Best liquidity
$46k
BingX
Tightest spread
+109.1 bps
BingX
Highest volume
$230k
BingX
Settlement mix
USDT · 2/2

Best Liquidity

BSX

Tightest Spread

BSX

Highest Volume

BSX

Venue Matrix

2 markets
Trade
BingXTradeBSX-USDTtrading44.950+4.38%+109.1 bps$46k$230k$872USDT-
Gate.ioTradeBSX/USDTtrading44.970+10.95%+169.0 bps$13k$7k$162USDT20x

Company data

Company fundamentals

Updated 4h ago
Market cap
$67.0B
Updated 4h ago
Revenue
$20.6B
Trailing 12 months
Net income
$3.6B
Trailing 12 months
Free cash flow
$3.4B
Trailing 12 months
Profit margin
17.2%
P/E
18.8
P/S
3.3
Revenue estimate
$21.6B
Next fiscal year
Revenue growth
+8%
Next fiscal year

Fundamental detail

Annual + quarterly
Latest revenue$20.1B
Net margin+14.4%
Free cash flow$3.7B
Net debt$10.4B
2020$9.9B
2021$11.9B
2022$12.7B
2023$14.2B
2024$16.7B
2025$20.1B
PeriodRevenueGrowthNet incomeFCF
2020$9.9B-8%$-82.0M$1.1B
2021$11.9B+20%$1.0B$1.3B
2022$12.7B+7%$698.0M$914.0M
2023$14.2B+12%$1.6B$1.7B
2024$16.7B+18%$1.9B$2.6B
2025$20.1B+20%$2.9B$3.7B
PeriodGross marginOperating marginNet marginROEROA
2020+56.2%+6.1%-0.8%-0.5%-0.3%
2021+62.8%+16.2%+8.7%+6.3%+3.2%
2022+60.8%+14.4%+5.5%+4.0%+2.1%
2023+62.0%+15.3%+11.2%+8.3%+4.5%
2024+61.3%+15.7%+11.1%+8.5%+4.7%
2025+69.0%+19.8%+14.4%+11.9%+6.6%
PeriodCashDebtNet debtCurrent ratio
2020$1.7B$9.5B$7.8B1.82
2021$1.9B$9.5B$7.5B1.48
2022$928.0M$9.3B$8.4B1.51
2023$865.0M$9.5B$8.6B1.32
2024$414.0M$11.1B$10.7B1.08
2025$2.0B$12.4B$10.4B1.62
PeriodMarket capEnterprise valueP/SP/E
2020$50.9B$58.7B5.1-442.7
2021$60.4B$67.9B5.161.3
2022$66.2B$74.5B5.2103.1
2023$84.0B$92.6B5.953.5
2024$131.4B$142.2B7.870.9
2025$141.2B$151.5B7.048.6
Q2 2024$4.1B
Q3 2024$4.2B
Q4 2024$4.6B
Q1 2025$4.7B
Q2 2025$5.1B
Q3 2025$5.1B
Q4 2025$5.3B
Q1 2026$5.2B
PeriodRevenueGrowthNet incomeFCF
Q2 2024$4.1B+14%$324.0M$658.0M
Q3 2024$4.2B+19%$469.0M$698.0M
Q4 2024$4.6B+22%$566.0M$1.2B
Q1 2025$4.7B+21%$674.0M$354.0M
Q2 2025$5.1B+23%$793.0M$1.1B
Q3 2025$5.1B+20%$755.0M$1.2B
Q4 2025$5.3B+16%$668.0M$1.0B
Q1 2026$5.2B+12%$1.3B$171.0M
PeriodGross marginOperating marginNet marginROEROA
Q2 2024+62.7%+18.1%+7.9%+1.6%+0.9%
Q3 2024+62.9%+16.0%+11.1%+2.3%+1.2%
Q4 2024+58.6%+12.9%+12.4%+2.6%+1.4%
Q1 2025+63.3%+19.2%+14.5%+3.0%+1.7%
Q2 2025+67.7%+16.2%+15.7%+3.5%+1.9%
Q3 2025+69.9%+20.7%+14.9%+3.2%+1.8%
Q4 2025+74.5%+22.8%+12.6%+2.8%+1.5%
Q1 2026+69.4%+20.6%+25.7%+5.2%+3.0%
PeriodCashDebtNet debtCurrent ratio
Q2 2024$2.9B$10.9B$8.0B1.61
Q3 2024$2.5B$11.3B$8.8B1.48
Q4 2024$414.0M$11.1B$10.7B1.08
Q1 2025$725.0M$11.7B$11.0B1.45
Q2 2025$534.0M$12.0B$11.5B1.37
Q3 2025$1.3B$12.0B$10.8B1.51
Q4 2025$2.0B$12.4B$10.4B1.62
Q1 2026$1.5B$11.0B$9.5B1.90
PeriodMarket capEnterprise valueP/SP/E
Q2 2024$112.4B$120.4B27.386.7
Q3 2024$123.4B$132.2B29.365.8
Q4 2024$131.7B$142.4B28.958.2
Q1 2025$149.0B$160.0B32.055.3
Q2 2025$158.8B$170.3B31.449.7
Q3 2025$144.7B$155.4B28.647.9
Q4 2025$141.4B$151.7B26.753.0
Q1 2026$93.2B$102.7B17.917.4

Refreshed 4h ago

Research data

Estimates, events and peers

Estimates

6 periods
FY 2026$21.6B+8%22 analysts
FY 2027$23.3B+16%22 analysts
FY 2028$25.2B+25%24 analysts
FY 2029$27.8B+38%23 analysts
FY 2030$30.6B+52%15 analysts
Q1 2027$5.6B+8%7 analysts

Events

Earnings · dividends · splits
2026-07-29EarningsRevenue est. $5.4B
2026-04-22EarningsRevenue est. $5.2B
2026-02-04EarningsRevenue est. $5.3B
2025-10-22EarningsRevenue est. $5.0B
2025-07-23EarningsRevenue est. $4.9B
2025-04-23EarningsRevenue est. $4.6B

Peer comparison

Similar listed perps